Active surveillance of vaccine safety: a system to detect early signs of adverse events
- PMID: 15824549
- DOI: 10.1097/01.ede.0000155506.05636.a4
Active surveillance of vaccine safety: a system to detect early signs of adverse events
Abstract
Background: There currently are no population-based systems in the United States to rapidly detect adverse events after newly introduced vaccines. To evaluate the feasibility of developing such systems, we used 5 years of data from 4 health maintenance organizations within the Centers for Disease Control and Prevention (CDC) Vaccine Safety Datalink.
Methods: Within every year, each week's vaccinated children were followed for 4 weeks, and rates of adverse events were compared with rates among children of similar ages before the introduction of the new vaccine. We assessed risks for intussusception after rotavirus vaccination and risks for fever, seizures, and other neurologic adverse events after the change from whole cell diphtheria-tetanus-pertussis (DTPw) to acellular DTP vaccine (DTPa). We used sequential probability ratio testing, adjusted for age, sex, calendar time, season, and HMO, and with a stopping value based on the probability of an adverse event under the null hypothesis and under a preset alternative hypothesis.
Results: We detected an increase in intussusception after 2589 vaccine doses of rotavirus vaccine, about the same time initial reports of intussusception were made to the Vaccine Adverse Events Reporting System. Decreases in risk for fever, seizures, and other abnormal neurologic events became detectable within 12 weeks, 42 weeks, and 18 months, respectively, after the change from DTPw to DTPa.
Conclusions: We conclude that it is feasible to develop systems for rapid and routine population-based assessments of new vaccine safety.
Similar articles
-
Value of Post-Licensure Data on Benefits and Risks of Vaccination to Inform Vaccine Policy: The Example of Rotavirus Vaccines.Am J Prev Med. 2015 Dec;49(6 Suppl 4):S377-82. doi: 10.1016/j.amepre.2015.09.005. Am J Prev Med. 2015. PMID: 26590437 Review.
-
Safety of second-generation rotavirus vaccines, intussusception.Curr Opin Pediatr. 2014 Feb;26(1):101-5. doi: 10.1097/MOP.0000000000000051. Curr Opin Pediatr. 2014. PMID: 24335963 Review.
-
Postlicensure monitoring of intussusception after RotaTeq vaccination in the United States, February 1, 2006, to September 25, 2007.Pediatrics. 2008 Jun;121(6):1206-12. doi: 10.1542/peds.2007-3793. Pediatrics. 2008. PMID: 18519491
-
An analysis of rotavirus vaccine reports to the vaccine adverse event reporting system: more than intussusception alone?Pediatrics. 2004 Apr;113(4):e353-9. doi: 10.1542/peds.113.4.e353. Pediatrics. 2004. PMID: 15060267
-
The safety of acellular pertussis vaccine vs whole-cell pertussis vaccine. A postmarketing assessment.Arch Pediatr Adolesc Med. 1996 May;150(5):457-60. doi: 10.1001/archpedi.1996.02170300011001. Arch Pediatr Adolesc Med. 1996. PMID: 8620224
Cited by
-
Mining adverse events in large frequency tables with ontology, with an application to the vaccine adverse event reporting system.Stat Med. 2023 May 10;42(10):1512-1524. doi: 10.1002/sim.9684. Epub 2023 Feb 15. Stat Med. 2023. PMID: 36791465 Free PMC article.
-
A seasonality-adjusted sequential test for vaccine safety surveillance.Biometrics. 2023 Dec;79(4):3533-3548. doi: 10.1111/biom.13829. Epub 2023 Jan 30. Biometrics. 2023. PMID: 36645553 Free PMC article.
-
Active Postlicensure Safety Surveillance for Recombinant Zoster Vaccine Using Electronic Health Record Data.Am J Epidemiol. 2023 Feb 1;192(2):205-216. doi: 10.1093/aje/kwac170. Am J Epidemiol. 2023. PMID: 36193854 Free PMC article.
-
A tree-based scan statistic for zero-inflated count data in post-market drug safety surveillance.Sci Rep. 2022 Sep 29;12(1):16299. doi: 10.1038/s41598-022-19998-5. Sci Rep. 2022. PMID: 36175526 Free PMC article.
-
A Case-Based Monitoring Approach to Evaluate Safety of COVID-19 Vaccines in a Partially Integrated Health Information System: A Study Protocol.Front Pharmacol. 2022 Jul 13;13:834940. doi: 10.3389/fphar.2022.834940. eCollection 2022. Front Pharmacol. 2022. PMID: 35910370 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical